Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine in acute depression
NCT02378415Phase 1Terminated
- Sponsor
- Naval Medical Center San Diego
- Start
- Dec 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ketamine in major depressive disorder (MDD) (2 arms), sponsored by Naval Medical Center San Diego. Primary endpoints: Beck Scale for Suicide Ideation at 240 months and Beck Hopelessness Scale at 240 months. Started Dec 2011; status: terminated.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02378415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02378415.